Jefferies Financial Group
BBNX icon

Jefferies Financial Group’s Beta Bionics BBNX Stock Holding History

Jefferies Financial Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.71M Buy
+90,015
New +$1.62M 0.01% 622
2026
Q1 		– Sell
-51,400
Closed -$1.57M – 2303
2025
Q4 		$1.57M Buy
+51,400
New +$1.37M 0.01% 906

Other funds holding BBNX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ING Group
ING Group Amsterdam, Netherlands $17.7B AUM 39.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Jefferies Financial Group's BBNX Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Beta Bionics (BBNX) in Q3 2026: 90,015 shares worth $1.71M. The stake represents 0.01% of the portfolio and ranks #622 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in BBNX as recently as Q4 2025.

Jefferies Financial Group first reported a position in BBNX in Q4 2025 and has held it in 2 quarters since. 64 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • Jefferies Financial Group held 90,015 shares of Beta Bionics worth $1.71M as of Q3 2026.
  • Beta Bionics was a new Jefferies Financial Group position in Q3 2026.
  • Beta Bionics made up 0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #622 holding.
  • Jefferies Financial Group first reported a position in Beta Bionics in Q4 2025 and has held it in 2 quarters since.
  • 64 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.